NFKB1 and pancreatic neoplasm: We previously reported that the synthetic protease inhibitor nafamostat mesilate (NM), commonly used in Japan for pancreatitis and disseminated intravascular coagulation (DIC), suppresses NF-κB activity and induces antitumor actions on pancreatic cancer [16].